These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1348208)

  • 21. Linkage analysis of hereditary thyroid carcinoma with and without pheochromocytoma.
    Narod SA; Sobol H; Nakamura Y; Calmettes C; Baulieu JL; Bigorgne JC; Chabrier G; Couette J; de Gennes JL; Duprey J
    Hum Genet; 1989 Nov; 83(4):353-8. PubMed ID: 2572534
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clonal selection: in the beginning a cell was chosen.
    Hecht F; Hecht BK
    Cancer Genet Cytogenet; 1992 Mar; 59(1):79. PubMed ID: 1348209
    [No Abstract]   [Full Text] [Related]  

  • 23. Cytogenetic studies of individuals from four kindreds with multiple endocrine neoplasia type II syndrome.
    Butler MG; Rames LJ; Joseph GM
    Cancer Genet Cytogenet; 1987 Oct; 28(2):253-60. PubMed ID: 2887277
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surgical treatment of medullary carcinoma of the thyroid.
    Block MA
    Otolaryngol Clin North Am; 1990 Jun; 23(3):453-73. PubMed ID: 1973281
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytogenetics of multiple endocrine neoplasia syndromes. III. Analysis of an insulinoma from a subject with MEN 1 by chromosome painting.
    Maraschio P; Pezzolo A; Brandi ML; Cortinovis M; Dainotti E; Scappaticci S; Fraccaro M
    Cancer Genet Cytogenet; 1993 Oct; 70(1):68-70. PubMed ID: 8106142
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spontaneous and induced chromosome damage in lymphocytes of medullary thyroid carcinoma patients and their family members.
    Tsioupra K; West LF; Davis MB; Parrington JM; Delhanty JD
    Dis Markers; 1988 Jun; 6(2):127-32. PubMed ID: 2456871
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cytogenetic changes in benign thyroid gland hyperplasias and adenomas correlated with histology].
    Belge G; Roque L; Thode B; Fonseca E; Soares J; Clode A; Bartnitzke S; Castedo S; Bullerdiek J
    Verh Dtsch Ges Pathol; 1997; 81():151-6. PubMed ID: 9474866
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chromosome 20 deletion in multiple endocrine neoplasia type 2: expanded double-blind studies.
    Babu VR; Van Dyke DL; Flejter WL; Jackson CE
    Am J Med Genet; 1987 Jul; 27(3):739-48. PubMed ID: 2888311
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The molecular biology of medullary thyroid carcinoma. A model for cancer development and progression.
    Nelkin BD; de Bustros AC; Mabry M; Baylin SB
    JAMA; 1989 Jun; 261(21):3130-5. PubMed ID: 2654432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of multiple endocrine neoplasia type 2A does not involve substantial deletions of chromosome 10.
    Landsvater RM; Mathew CG; Smith BA; Marcus EM; te Meerman GJ; Lips CJ; Geerdink RA; Nakamura Y; Ponder BA; Buys CH
    Genomics; 1989 Apr; 4(3):246-50. PubMed ID: 2565874
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytogenetic study of a nodular hyperplasia of the thyroid after irradiation for Hodgkin's disease.
    van den Berg E; van Doormaal JJ; Oosterhuis JW; de Jong B; Buist J; Vos AM; Dam A; Vermeij A
    Cancer Genet Cytogenet; 1991 May; 53(1):15-21. PubMed ID: 2036636
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mapping the inherited defects associated with multiple endocrine neoplasia type 2A, multiple endocrine neoplasia type 2B, and familial medullary thyroid carcinoma to chromosome 10 by linkage analysis.
    Goodfellow PJ
    Endocrinol Metab Clin North Am; 1994 Mar; 23(1):177-85. PubMed ID: 7913024
    [No Abstract]   [Full Text] [Related]  

  • 33. Multiple endocrine neoplasia type 2A (MEN-2A): natural history, screening, and central registration.
    Brouwers-Smalbraak GJ; Vasen HF; Struyvenberg A; Nieuwenhuijzen Kruseman AC; Helsloot MH; Lips CJ
    Neth J Med; 1986; 29(4):111-7. PubMed ID: 2872602
    [No Abstract]   [Full Text] [Related]  

  • 34. Hereditary medullary thyroid carcinoma.
    Vasen HF; Vermey A
    Cancer Detect Prev; 1995; 19(2):143-50. PubMed ID: 7750101
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Translocation (5;19)(q13;q13) in a multinodular thyroid goiter.
    Cigudosa JC; Pedrosa Guerra A; Otero Gómez A; Carrasco Juan JL; Pérez Gómez JA; Ferrer Roca OF; García Miranda JL
    Cancer Genet Cytogenet; 1995 Jul; 82(1):67-9. PubMed ID: 7627938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. C-cell hyperplasia and medullary thyroid carcinoma: clinicopathological and genetic correlations in 66 consecutive patients.
    Guyétant S; Josselin N; Savagner F; Rohmer V; Michalak S; Saint-André JP
    Mod Pathol; 2003 Aug; 16(8):756-63. PubMed ID: 12920219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surgical treatment of medullary thyroid carcinoma in a thirteen-year-old girl with MEN 2B.
    Tisell LE; Jansson S
    Henry Ford Hosp Med J; 1989; 37(3-4):157-9. PubMed ID: 2576953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A cytogenetic study of familial medullary carcinoma of the thyroid.
    Wurster-Hill DH; Noll WW; Bircher LY; Devlin J; Schultz E
    Cancer Res; 1986 Apr; 46(4 Pt 2):2134-8. PubMed ID: 2418963
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chromosome instability in patients with medullary carcinoma of the thyroid.
    Hsu TC; Pathak S; Samaan N; Hickey RC
    JAMA; 1981 Nov; 246(18):2046-8. PubMed ID: 6116812
    [No Abstract]   [Full Text] [Related]  

  • 40. [Medullary carcinoma of the thyroid: a case of multiple endocrine neoplasia type 2A].
    Pati M; Sperti P; Magiar AV; Bonifacio V
    Minerva Endocrinol; 1994 Mar; 19(1):29-32. PubMed ID: 7913514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.